全文获取类型
收费全文 | 2472篇 |
免费 | 115篇 |
国内免费 | 101篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 27篇 |
妇产科学 | 33篇 |
基础医学 | 382篇 |
口腔科学 | 55篇 |
临床医学 | 224篇 |
内科学 | 411篇 |
皮肤病学 | 92篇 |
神经病学 | 110篇 |
特种医学 | 163篇 |
外科学 | 347篇 |
综合类 | 84篇 |
一般理论 | 1篇 |
预防医学 | 111篇 |
眼科学 | 10篇 |
药学 | 227篇 |
中国医学 | 13篇 |
肿瘤学 | 379篇 |
出版年
2023年 | 15篇 |
2022年 | 57篇 |
2021年 | 78篇 |
2020年 | 35篇 |
2019年 | 56篇 |
2018年 | 63篇 |
2017年 | 50篇 |
2016年 | 77篇 |
2015年 | 116篇 |
2014年 | 142篇 |
2013年 | 174篇 |
2012年 | 230篇 |
2011年 | 190篇 |
2010年 | 114篇 |
2009年 | 108篇 |
2008年 | 129篇 |
2007年 | 166篇 |
2006年 | 110篇 |
2005年 | 113篇 |
2004年 | 73篇 |
2003年 | 72篇 |
2002年 | 51篇 |
2001年 | 47篇 |
2000年 | 50篇 |
1999年 | 39篇 |
1998年 | 34篇 |
1997年 | 29篇 |
1996年 | 30篇 |
1995年 | 24篇 |
1994年 | 13篇 |
1993年 | 22篇 |
1992年 | 13篇 |
1991年 | 14篇 |
1990年 | 11篇 |
1989年 | 19篇 |
1988年 | 6篇 |
1987年 | 16篇 |
1986年 | 11篇 |
1985年 | 17篇 |
1984年 | 4篇 |
1983年 | 7篇 |
1982年 | 8篇 |
1981年 | 10篇 |
1980年 | 6篇 |
1978年 | 3篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1964年 | 3篇 |
1957年 | 3篇 |
排序方式: 共有2688条查询结果,搜索用时 15 毫秒
81.
82.
Ahn YS Kim HY Hong SM Patton LL Kim JH Noh HJ 《International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children》2012,22(4):292-301
International Journal of Paediatric Dentistry 2012; 22: 292–301 Objectives. The purpose of this study was to assess reliability, discriminant validity, and convergent validity of the Oral Health Impact Profile (COHIP) Korean version in a representative community sample of 8‐ to 15‐year‐old Korean children. Methods. A Korean version of COHIP was developed according to the standard procedure of cross‐cultural adaptation of self‐reported instruments. A representative community sample of 2236 schoolchildren was selected by cluster sampling method. Results. Mean age of the participants was 11.8 years. Mean and median of the overall COHIP score were 103.3 (SD 13.3) and 106, respectively. Internal reliability and retest reliability were excellent with Chronbach’s alpha 0.88 and intraclass correlation coefficient 0.88. Face validity was confirmed with 98% of participants reporting the COHIP questionnaire was easy to answer. Nonclinical factors such as self‐rated oral health or satisfaction with oral health were significantly related with overall COHIP score and five subscale scores (P < 0.001) in a consistent manner. Children with carious permanent teeth and with orthodontic treatment need had highly significantly lower overall COHIP score (P < 0.01). Conclusion. The Korean version of the COHIP was successfully developed. The internal reliability, retest reliability, face validity, discriminant validity, and convergent validity of the COHIP Korean version were confirmed. 相似文献
83.
84.
Jung KH Noh JH Kim JK Eun JW Bae HJ Chang YG Kim MG Park WS Lee JY Lee SY Chu IS Nam SW 《Hepatology (Baltimore, Md.)》2012,56(2):644-657
Ubiquitin-binding histone deacetylase 6 (HDAC6) is uniquely endowed with tubulin deacetylase activity and plays an important role in the clearance of misfolded protein by autophagy. In cancer, HDAC6 has become a target for drug development due to its major contribution to oncogenic cell transformation. In the present study we show that HDAC6 expression was down-regulated in a large cohort of human hepatocellular carcinoma (HCC) patients, and that low expression of HDAC6 was significantly associated with poor prognosis of HCC patients in 5-year overall, disease-free, and recurrence-free survival. Notably, we observed that ectopic overexpression of HDAC6 suppressed tumor cell growth and proliferation in various liver cancer cells, and elicited increased LC3B-II conversion and autophagic vacuole formation without causing apoptotic cell death or cell cycle inhibition. In addition, the sustained overexpression of HDAC6 reduced the in vivo tumor growth rate in a mouse xenograft model. It was also found that HDAC6 mediated autophagic cell death by way of Beclin 1 and activation of the LC3-II pathway in liver cancer cells, and that HDAC6 overexpression activated c-Jun NH2-terminal kinase (JNK) and increased the phosphorylation of c-Jun. In contrast, the induction of Beclin 1 expression was blocked by SP600125 (a specific inhibitor of JNK) or by small interfering RNA directed against HDAC6. CONCLUSION: Our findings suggest that loss of HDAC6 expression in human HCCs and tumor suppression by HDAC6 occur by way of activation of caspase-independent autophagic cell death through the JNK/Beclin 1 pathway in liver cancer and, thus, that a novel tumor suppressor function mechanism involving HDAC6 may be amenable to nonepigenetic regulation. 相似文献
85.
86.
Ohba K Noh JY Unno T Satoh T Iwahara K Matsushita A Sasaki S Oki Y Nakamura H 《Endocrine journal》2012,59(8):663-667
The syndrome of inappropriate secretion of thyrotropin (SITSH) is defined as the inappropriate non-suppression of serum TSH in the presence of elevated free thyroid hormone; TSH-secreting pituitary adenomas and the syndrome of resistance to thyroid hormone are the main etiologies of SITSH. In addition, erroneous thyroid function testing may result in the diagnosis of this syndrome. A 63-year-old woman was referred because of suspected SITSH. Laboratory tests showed a normal TSH (0.52 μIU/L; normal range: 0.5-5.0) measured by sandwich Elecsys, and elevated FT4 (3.8 ng/dL; normal range: 0.9-1.6) and FT3 (7.6 pg/mL; normal range: 2.3-4.0), determined by competitive Elecsys. To exclude possible assay interference, aliquots of the original samples were retested using a different method (ADVIA Centaur), which showed normal FT4 and FT3 levels. Eight hormone levels, other than thyroid function tests measured by competitive or sandwich Elecsys, were higher or lower than levels determined by an alternative analysis. Subsequent examinations, including gel filtration chromatography, suggested interference by substances against ruthenium, which reduced the excitation of ruthenium, and resulted in erroneous results. The frequency of similar cases, where the FT4 was higher than 3.2 ng/dL, in spite of a non-suppressed TSH, was examined; none of 10 such subjects appeared to have method-specific interference. Here, a patient with anti-ruthenium interference, whose initial thyroid function tests were consistent with SITSH, is presented. This type of interference should be considered when thyroid function is measured using the Elecsys technique, although the frequency of such findings is likely very low. 相似文献
87.
Suk Bae Kim Il Han Song Young Min Kim Ran Noh Ha Yan Kang Hyang Ie Lee Hyeon Yoong Yang An Na Kim Hee Bok Chae Sae Hwan Lee Hong Soo Kim Tae Hee Lee Young Woo Kang Eaum Seok Lee Seok Hyun Kim Byung Seok Lee Heon Young Lee 《World journal of gastroenterology : WJG》2012,18(47):6943-6950
AIM: To evaluate the treatment outcomes of clevudine compared with entecavir in antiviral-naive patients with chronic hepatitis B (CHB).METHODS: We retrospectively analyzed the clinical data of CHB patients treated with clevudine 30 mg/d and compared their clinical outcomes with patients treated with entecavir 0.5 mg/d. The biochemical response, as assessed by serum alanine aminotransferase (ALT) activity, virologic response, as assessed by serum hepatitis B virus DNA (HBV DNA) titer, serologic response, as assessed by hepatitis B e antigen (HBeAg) status, and virologic breakthrough with genotypic mutations were assessed.RESULTS: Two-hundred and fifty-four patients [clevudine (n = 118) vs entecavir (n = 136)] were enrolled. In clevudine-treated patients, the cumulative rates of serum ALT normalization were 83.9% at week 48 and 91.5% at week 96 (80.9% and 91.2% in the entecavir group, respectively), the mean titer changes in serum HBV DNA were -6.03 and -6.55 log10 copies/mL (-6.35 and -6.86 log10 copies/mL, respectively, in the entecavir group), and the cumulative non-detection rates of serum HBV DNA were 72.6% and 83.1% (74.4% and 83.8%, respectively, in the entecavir group). These results were similar to those of entecavir-treated patients. The cumulative rates of HBeAg seroconversion were 21.8% at week 48 and 25.0% at week 96 in patients treated with clevudine, which was similar to patients treated with entecavir (22.8% and 27.7%, respectively). The virologic breakthrough in the clevudine group occurred in 9 (7.6%) patients at weeks 48 and 15 (12.7%) patients at week 96, which primarily corresponded to genotypic mutations of rtM204I and/or rtL180M. There was no virologic breakthrough in the entecavir group.CONCLUSION: In antiviral-naive CHB patients, long-term treatment outcomes of clevudine were not inferior to those of entecavir, except for virologic breakthrough. 相似文献
88.
89.
Lee BI Hong SP Kim SE Kim SH Kim HS Hong SN Yang DH Shin SJ Lee SH Kim YH Park DI Kim HJ Yang SK Kim HJ Jeon HJ;Multi-Society Task Force for Development of Guidelines for Colorectal Polyp Screening Surveillance Management 《Taehan Sohwagi Hakhoe chi》2012,59(2):65-84
Colorectal cancer is the second most common cancer in males and the fourth most common in females in Korea. Since the most of colorectal cancer occur through the prolonged transformation of adenomas into carcinomas, early detection and removal of colorectal adenomas are one of the most effective methods to prevent colorectal cancer. Considering the increasing incidence of colorectal cancer and polyps in Korea, it is very important to establish Korean guideline for colorectal cancer screening and polyp detection. Korean Multi-Society Take Force developed the guidelines with evidence-based methods. Parts of the statements drawn by systematic reviews and meta-analyses. Herein we discussed the epidemiology of colorectal cancers and adenomas in Korea, optimal screening methods for colorectal cancer, and detection for adenomas including fecal occult blood tests, radiologic tests, and endoscopic examinations. 相似文献
90.